1d
Investor's Business Daily on MSNIBD Stock Of The Day: Meta Tests Key Level After Record-Setting Rally EndsMeta stock pulled back this week following a record-setting rally, but shares are finding support at their 21-day line.
1d
Investor's Business Daily on MSNThese Biotech Stocks Aren't Profitable But Still Make Elite IBD 50A handful of biotech stocks made an elite list despite being unprofitable. But many show robust sales growth and constructive ...
A new era at IBD began nearly a year ago with the launch of MarketSurge, a makeover of the MarketSmith charting and research product that included a new brand name, new logo and a number of new ...
42,045 people played the daily Crossword recently. Can you solve it faster than others?42,045 people played the daily Crossword recently. Can you solve it faster than others? Simply Wall St. Warren ...
This TIPS ETF hits a new 52-week high. Are more gains in store for this ETF? Autohome Inc (ATHM) reports robust financial performance with significant NEV revenue growth and strategic offline ...
The expert considers that biomarkers could greatly benefit the broader inflammatory bowel disease (IBD) field if they are easy to assess and help predict clinical response. While Teva/Sanofi’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results